crowd people, people walking the street, woman in focus, mask, QFT, QuantiFeron, immune response

COVID-19

QuantiFERON SARS-CoV-2 RUO

Maximize insights from SARS-CoV-2 T cell immune response

T cells are increasingly recognized for their role in SARS-CoV-2 infection and immunity, and the exploration of immune response markers during COVID-19 infection is becoming the next tool for researching potential improvements in patient management and vaccination guidance in the future.

To control the pandemic, we must first understand and control the infection. Exploration of immune response markers in SARS-CoV-2 infections is emerging as the next research tool as T cells are becoming increasingly recognized for their role in COVID-19 immunity.

Why T cells? Learn the answer from top scientists

In the fight against COVID-19, antibodies generated in response to a vaccine have taken center stage. What about the other arm of the adaptive immune response – T cells? T cells hunt and kill virus-infected cells and trigger cascades of other immune reactions, making them a critical part of the immune response.

Join three experts as they describe their latest research into SARS-CoV-2 T cell responses – and challenge us to look at T cells differently.

Watch the webinar

Easily assess cell-mediated immune response

QuantiFERON SARS-CoV-2 RUO solution is an original combination of blood collection tubes containing innovative specific peptides formulated to stimulate lymphocytes in heparinized whole blood involved in cell-mediated immunity. Plasma from the stimulated samples can then be used for detection of IFN-y using a simple ELISA.

Based on world-leading QuantiFERON IGRA technology
Customizable solution to fit your research needs
Unlock immune response potential for better research insights

	Starter Set	Extended Set	Monitor Direct
Description	The easy way to START SARS-CoV-2 immune response investigation	Additional peptides to EXTEND immune response research on SARS-CoV-2;	EVALUATE immune response; now simply in a tube
Content	Original combination of specific peptides from the spike antigen (S1, S2, RBD subdomains) eliciting CD4 (Ag1) and CD4+CD8 (Ag2) T cells immune responses	Contains additional specific peptides, covering the S, N and M domains, and other domains from the full genome of SARS-CoV-2 to elicit a more complete specific T cell-mediated immune response	Unique association of Toll-like Receptor (TLR) agonists and T-cell receptor (TCR) agonists to stimulate different cell types involved in both the innate and adaptive immune system.
Research areas	Research previous exposure and/or when there are low/ undetectable levels of antibodies >Research immune response post vaccination	Maximize immune response research capabilities by stimulating multiple antigenic targets in natural infection Research immune response after vaccination with non spike-basedonly vaccines	Research IFN-γ kinetics in SARS-CoV-2 infection Helps research on COVID-19 severity assessment Helps research on COVID-19 outcomes in hospitalized patients

The QuantiFERON SARS-CoV-2 Blood Collection Tubes and QuantiFERON ELISA are for Research Use Only and not for diagnostic use.